Who Paid My Doc
Ashley Bateman
Adolescent Medicine Malibu, CA Medical Doctor
NPI 1275769887 CMS profile 428977
23815 Stuart Ranch Rd Ste 300, Malibu, CA 90265
General payments
$157
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Ashley Bateman of Malibu, CA is reported in the CMS Open Payments database as having received $157 across 4 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $39 | 2 | |
| 2021 | General | $118 | 2 |
Beside peers
- Ashley Bateman
- Adolescent Medicine median
- Middle half of Adolescent Medicine
- National median
In program year 2025, general payments to Ashley Bateman were reported at $0. Among 40 Adolescent Medicine profiles paid that year, the median was $135 and the middle half received between $78 and $573.
Show as a table
| Year | Ashley Bateman | Adolescent Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $112 | $24–$444 | $163 |
| 2020 | $0 | $80 | $35–$250 | $114 |
| 2021 | $118 | $229 | $55–$448 | $132 |
| 2022 | $0 | $162 | $35–$492 | $149 |
| 2023 | $39 | $182 | $54–$507 | $160 |
| 2024 | $0 | $142 | $59–$362 | $164 |
| 2025 | $0 | $135 | $78–$573 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 77 drugsPart D claims
2,598
Drug cost
$91,601
Branded share of claims
18%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 44 | $35,852 | |
| Celebrex Celecoxib | Brand | 12 | $6,764 | |
| Myrbetriq Mirabegron | Brand | 14 | $6,691 | |
| Levothyroxine Sodium | Generic | 119 | $2,760 | |
| Estradiol | Generic | 36 | $2,060 | |
| Rosuvastatin Calcium | Generic | 126 | $1,937 | |
| Atorvastatin Calcium | Generic | 187 | $1,831 | |
| Bupropion Xl Bupropion Hcl | Brand | 64 | $1,658 | |
| Synthroid Levothyroxine Sodium | Brand | 26 | $1,416 | |
| Valacyclovir Valacyclovir Hcl | Brand | 47 | $1,365 |
The 10 drugs with the highest cost, of 77 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 83 billing codesPaid by Medicare
$114,979
Medicare patients
265
Services billed
3,636
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 54% | |
| Arthritis | 45% | |
| Ischemic heart disease | 24% | |
| Osteoporosis | 23% | |
| Depression | 22% | |
| Chronic kidney disease | 15% | |
| Cancer | 15% | |
| Atrial fibrillation | 14% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, denosumab, 1 mg J0897 | Office | 13 | 1,140 | $23,212 |
| Sarscv2 vac 30mcg trs-suc im 91320 | Office | 42 | 42 | $6,247 |
| Vaccine for influenza for injection into muscle 90662 | Office | 47 | 48 | $3,878 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg J3420 | Office | 18 | 32 | $29 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
4 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adolescent Medicine in California
Anahit Blikian
Adolescent Medicine · Glendale, CA
Mohamad Kadri
Adolescent Medicine · Los Angeles, CA
Jay Madhure
Adolescent Medicine · Mission Hills, CA
Priyanka Kallem
Adolescent Medicine · Pleasanton, CA
Tracey Norton
Adolescent Medicine · Los Angeles, CA
Kyung Yoo
Adolescent Medicine · North Hills, CA
Related records
Adolescent Medicine in California
Practitioners in the same specialty and state, ranked by reported value.
All Adolescent Medicine
Everyone recorded under this specialty, nationwide.
Doctors in California
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.